Next 10 |
Innoviva, Inc. (Nasdaq: INVA) (“Innoviva”), a diversified holding company with a portfolio of royalties and a growing portfolio of innovative healthcare assets, today announced that its tender offer to purchase any and all issued and outstanding shares of common stock of L...
NEW YORK, NY / ACCESSWIRE / August 4, 2022 / Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: RealNetworks, Inc. (NASDAQ:RNWK)'s ...
NEW YORK, NY / ACCESSWIRE / July 19, 2022 / Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: La Jolla Pharmaceutical Company (NAS...
The biotech investment sector has always been its own market, very distinct from other sectors. So it was no surprise that when most sectors turned slowly upward after the pandemic-inspired crash, Biotech (XBI) rose 164%, exceeding the overall market (SPY) performance by triple digits. Then, a...
NEW YORK, NY / ACCESSWIRE / July 13, 2022 / Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Hemisphere Media Group, Inc. (NASDAQ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips In a development that’s garnering attention in the healthcare sector, La Jolla Pharmaceutical (NASDAQ: LJPC ) has reportedly consented to be acquired by Innovia (NASDAQ: INVA ). As a result, LJPC stock ...
Penny Stocks To Buy If you want to make money in the stock market today and do it quickly, penny stocks might be on your watch list. According to the definition, we’re talking about stocks trading below $5. But for some, they look for much cheaper stocks to buy. Penny Stocks ...
Innoviva, Inc. ( INVA ), a diversified holding company has agreed to acquire the commercial-stage biotech La Jolla Pharmaceutical Company ( NASDAQ: LJPC ) for $6.23 per share in cash implying an enterprise value of ~$149M, the companies announced on Monday. Per the ter...
Acquisition to strengthen Innoviva’s infectious disease and hospital portfolio with addition of GIAPREZA ® and XERAVA ® Innoviva, Inc. (Nasdaq: INVA), a diversified holding company with a portfolio of royalties and a growing portfolio of innovati...
La Jolla Pharmaceutical press release (NASDAQ:LJPC): Q1 GAAP EPS of $0.00 misses by $0.01. Revenue of $10.43M (-69.4% Y/Y) misses by $2.67M. “We are pleased to report that La Jolla continues to grow net product sales and generate positive operating cash flow,” said Larry Ed...
News, Short Squeeze, Breakout and More Instantly...
La Jolla Pharmaceutical Company Company Name:
LJPC Stock Symbol:
NASDAQ Market:
Innoviva, Inc. (Nasdaq: INVA) (“Innoviva”), a diversified holding company with a portfolio of royalties and a growing portfolio of innovative healthcare assets, today announced that its tender offer to purchase any and all issued and outstanding shares of common stock of L...
The biotech investment sector has always been its own market, very distinct from other sectors. So it was no surprise that when most sectors turned slowly upward after the pandemic-inspired crash, Biotech (XBI) rose 164%, exceeding the overall market (SPY) performance by triple digits. Then, a...